Evidence map›Paper›PMID 41345400›Full record

ArticleNPJ Parkinson's disease2025

Subitem-level multi-scale assessment and machine learning for three-class cognitive status classification in Parkinson's disease.

Ying-Che Chen, Rwei-Ling Yu, Sun-Yuan Hsieh

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ying-Che ChenThe Institute of Medical Informatics, National Cheng Kung University, Tainan, Taiwan (R.O.C.).
Rwei-Ling YuInstitute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan (R.O.C.).
Sun-Yuan HsiehThe Institute of Medical Informatics, National Cheng Kung University, Tainan, Taiwan (R.O.C.). hsiehsy@mail.ncku.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People with Parkinson's disease (PD) frequently develop cognitive impairments, and early accurate classification of cognitive status is critically important for clinical intervention. In this study, we leveraged data from the Parkinson's Progression Markers Initiative (PPMI) to develop a two-stage machine-learning framework that distinguishes among three cognitive states: PD with normal cognition (PD-NC), PD with mild cognitive impairment (PD-MCI), and PD dementia (PDD). Our approach combined SHapley Additive exPlanations (SHAP) for model interpretability with an ensemble of XGBoost and multilayer perceptron (MLP) classifiers, addressing class imbalance via the SMOTE-Tomek method. All model development and validation were conducted with a strict hold-out evaluation, with the test-set entirely excluded from feature selection, model training, and threshold optimization. Independent validation demonstrated strong and balanced classification performance across all cognitive subgroups, with particularly effective identification of cognitively impaired individuals requiring clinical attention. The area under the receiver operating characteristic curve (AUC) for three-class discrimination exceeded 0.85. Key predictors, including Montreal Cognitive Assessment (MoCA) scores and activities of daily living assessments, were validated as clinically meaningful by SHAP analysis. The proposed two-stage explainable model demonstrates strong and balanced classification performance across cognitive subgroups in PD. Its ability to identify people at high risk for dementia highlights its potential utility in clinical workflows, particularly as a scalable tool for early cognitive stratification and decision support in routine neurology practice. However, external validation on diverse real-world cohorts is warranted before clinical implementation.

Identifiers

PMID41345400
PMCPMC12769750

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.